Benedito A. Carneiro

Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial

Thomas Powles, Tibor Csőszi, Mustafa Özgüroğlu et al. · The Lancet Oncology · 2021 · 648 citations · Full text

Medicine, Oncology, Pharmacology +11

Genomic landscape of DNA repair genes in cancer

Young Kwang Chae, Jonathan F. Anker, Benedito A. Carneiro et al. · Oncotarget · 2016 · 176 citations · Full text

Life Sciences, Genetics, Oncology +17

Cabozantinib in advanced non-clear-cell renal cell carcinoma: a multicentre, retrospective, cohort study

Nieves Martínez Chanzá, Wanling Xie, Mehmet Asım Bilen et al. · The Lancet Oncology · 2019 · 175 citations

Medicine, Oncology, Pharmacology +11

Nivolumab in Metastatic Adrenocortical Carcinoma: Results of a Phase 2 Trial

Benedito A. Carneiro, Bhavana Konda, Rubens B. Costa et al. · The Journal of Clinical Endocrinology & Metabolism · 2019 · 117 citations · Full text

Medicine, Oncology, Pharmacology +16

Concordance between genomic alterations assessed by next-generation sequencing in tumor tissue or circulating cell-free DNA

Young Kwang Chae, Andrew A. Davis, Benedito A. Carneiro et al. · Oncotarget · 2016 · 112 citations · Full text

Medicine, Molecular Genetics, Oncology +17